Logo image of CHSCN

CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

USA - NASDAQ:CHSCN - US12542R5063

25.17 USD
+0.01 (+0.04%)
Last: 10/2/2025, 12:04:06 PM
Fundamental Rating

3

CHSCN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. While CHSCN is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCN is valued expensive and it does not seem to be growing. CHSCN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHSCN had a positive operating cash flow in the past year.
Each year in the past 5 years CHSCN has been profitable.
Each year in the past 5 years CHSCN had a positive operating cash flow.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

CHSCN has a Return On Assets of 2.61%. This is comparable to the rest of the industry: CHSCN outperforms 56.18% of its industry peers.
Looking at the Return On Equity, with a value of 4.76%, CHSCN is in line with its industry, outperforming 51.69% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.05%, CHSCN is doing worse than 60.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHSCN is significantly below the industry average of 27.78%.
The last Return On Invested Capital (0.05%) for CHSCN is well below the 3 year average (6.11%), which needs to be investigated, but indicates that CHSCN had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.42%, CHSCN is in line with its industry, outperforming 48.31% of the companies in the same industry.
CHSCN's Profit Margin has improved in the last couple of years.
The Operating Margin of CHSCN (0.02%) is worse than 60.67% of its industry peers.
CHSCN's Operating Margin has declined in the last couple of years.
CHSCN's Gross Margin of 2.99% is on the low side compared to the rest of the industry. CHSCN is outperformed by 86.52% of its industry peers.
CHSCN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCN is still creating some value.
The debt/assets ratio for CHSCN is higher compared to a year ago.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CHSCN has an Altman-Z score of 2.22. This is not the best score and indicates that CHSCN is in the grey zone with still only limited risk for bankruptcy at the moment.
CHSCN has a Altman-Z score of 2.22. This is comparable to the rest of the industry: CHSCN outperforms 51.69% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that CHSCN is not too dependend on debt financing.
CHSCN has a better Debt to Equity ratio (0.34) than 61.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC0.01
WACC4.7%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.40 indicates that CHSCN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, CHSCN is in line with its industry, outperforming 44.94% of the companies in the same industry.
A Quick Ratio of 0.86 indicates that CHSCN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.86, CHSCN is in line with its industry, outperforming 46.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

Looking at the last year, CHSCN shows a decrease in Revenue. The Revenue has decreased by -8.96% in the last year.
Measured over the past years, CHSCN shows a small growth in Revenue. The Revenue has been growing by 4.24% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

92.13% of the companies in the same industry are more expensive than CHSCN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.76
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.75%, CHSCN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.12, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 88.76% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CHSCN pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.75%

5.2 History

CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
CHSCN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCN pays out 32.94% of its income as dividend. This is a sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (10/2/2025, 12:04:06 PM)

25.17

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.67%
Inst Owner Change-91.8%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap308.84M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield 6.75%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years10
Ex-Date09-16 2025-09-16 (0.44375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.65
P/B 0.03
P/tB 0.03
EV/EBITDA 3.76
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY154.77%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.22
F-Score3
WACC4.7%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%